COMMUNIQUÉS West-GlobeNewswire

Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis with Cardiomyopathy
26/03/2025
CAMBRIDGE, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
26/03/2025
Event to highlight the differentiated features of Traws oral small molecule product candidates: Tivoxavir Marboxil, a single dose, CAP-dependent endonuclease inhibitor for Bird Flu Ratutrelvir, a main protease inhibitor [...]
Kura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting
26/03/2025
– Oral presentation to highlight preclinical data further supporting combination of KO-2806 with TKIs in ccRCC – – Company expects to present data from the Phase 1 FIT-001 trial evaluating KO-2806 and cabozantinib in [...]
Entourage Health Increases Senior Secured Credit Facility
26/03/2025
TORONTO, March 26, 2025 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V: ENTG ) ( OTCQX: ETRGF ) ( FSE: 4WE ) (" Entourage " or the " Company "), a Canadian producer and distributor of award-winning cannabis products [...]
PurDentix Probiotic Supplement: Ingredients, Benefits, Reviews & Where to Buy
26/03/2025
AURORA, Colo., March 26, 2025 (GLOBE NEWSWIRE) -- Maintaining optimal oral health is more crucial than ever in today's unhealthy world. Many struggle with gum disease, tooth decay, and oral hygiene, leading to a growing [...]
Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting
26/03/2025
Additional data from the MDNA11 ABILITY-1 trial to be presented at the Annual Meeting Pre-clinical data on Medicenna’s first-in-class Masked and Tumor Targeted Bifunctional anti-PD1-IL2 Superkine, MDNA113, will also be [...]
Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress
26/03/2025
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is being studied in multiple Phase 2b clinical trials with read-outs beginning mid-2025 Multiple data readouts in mid and late 2025 on track [...]
Nanox to Present New Data Featuring AI Bone Solution at Four Medical Conferences through June 2025 across Europe
26/03/2025
ADOPT Study Findings Highlight Nanox.AI’s Role in Enhancing Fracture Detection and Healthcare Cost Savings PETACH TIKVA, Israel, March 26, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: [...]
Financière de Tubize - Convening of the ordinary and extraordinary general meetings of shareholders of April 25, 2025
26/03/2025
Convening of the Ordinary and Extraordinary General Meetings of shareholders of 25 April 2025 The shareholders are invited to attend the ordinary and extraordinary general meetings, which will take place on Friday 25th [...]
Financière de Tubize - Convocation aux assemblées générales ordinaire et extraordinaire du 25/04/2025
26/03/2025
Convocation des actionnaires à l’Assemblée Générale Ordinaire et à l’Assemblée Générale Extraordinaire du 25 avril 2025 Les actionnaires sont invités à prendre part à l’assemblée générale ordinaire et à l’assemblée [...]
Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting
26/03/2025
LONDON and PHILADELPHIA, March 26, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads [...]
Microbix Further Optimizes Capital Usage and Availability
26/03/2025
Debt Repayment & Credit Expansion Provides Savings & Maintains Resilience MISSISSAUGA, Ontario, March 26, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences [...]
Hair Loss Hero: 2DDR HEALTHCARE Shares Results From Customer Driven Hair Loss Research Study
26/03/2025
2DDR HEALTHCARE, LLC reveals promising hair growth results with new serum, evidencing new hair growth within 6-12 weeks. Dover, Delaware, March 26, 2025 (GLOBE NEWSWIRE) -- 2DDR HEALTHCARE, LLC, a biosciences company [...]
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
26/03/2025
WEST CHESTER, Pa., March 26, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring [...]
Zymeworks Announces Participation in Upcoming Investor Conferences
26/03/2025
VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve [...]
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
26/03/2025
REYKJAVIK, Iceland, PISCATAWAY, N.J. and LONDON, March 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for [...]
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
26/03/2025
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical [...]
FDA Issues Nyxoah an Approvable Letter for its Genio® System
26/03/2025
INSIDE INFORMATION REGULATED INFORMATION FDA Issues Nyxoah an Approvable Letter for its Genio® System Mont-Saint-Guibert, Belgium – March 26, 2025, 8:00am CET / 3:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]
La FDA Délivre à Nyxoah une Lettre d'Approuvabilité pour son système Genio®
26/03/2025
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES La FDA Délivre à Nyxoah une Lettre d'Approuvabilité pour son Système Genio® Mont-Saint-Guibert, Belgique – 26 mars 2025, 8h00 CET / 3h00 ET – Nyxoah SA (Euronext [...]

Pages